Melissa Barlow, David Messenger, Ryan Preece, Amy Prowse, Gary Abel, Willie Hamilton, Samuel Wd Merriel, Adam Chambers, Sarah Er Bailey
{"title":"粪便免疫化学检测早发性结直肠癌的诊断准确性:英格兰西南部的年龄分层分析。","authors":"Melissa Barlow, David Messenger, Ryan Preece, Amy Prowse, Gary Abel, Willie Hamilton, Samuel Wd Merriel, Adam Chambers, Sarah Er Bailey","doi":"10.1038/s41416-025-03154-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.</p><p><strong>Methods: </strong>A cohort of 38,117 symptomatic patients aged 18-49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.</p><p><strong>Results: </strong>Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5-96.7%), specificity was 88.5% (88.2-88.8%), positive predictive value (PPV) was 2.2% (1.8-2.6%), and negative predictive value was 100% (100-100%). PPVs decreased in younger age groups (18-29, 30-39, 40-49 years).</p><p><strong>Conclusions: </strong>FIT performs excellently for patients aged 40-49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.</p>","PeriodicalId":9243,"journal":{"name":"British Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The diagnostic accuracy of the faecal immunochemical test for the detection of early-onset colorectal cancer: an age-stratified analysis in South West England.\",\"authors\":\"Melissa Barlow, David Messenger, Ryan Preece, Amy Prowse, Gary Abel, Willie Hamilton, Samuel Wd Merriel, Adam Chambers, Sarah Er Bailey\",\"doi\":\"10.1038/s41416-025-03154-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.</p><p><strong>Methods: </strong>A cohort of 38,117 symptomatic patients aged 18-49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.</p><p><strong>Results: </strong>Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5-96.7%), specificity was 88.5% (88.2-88.8%), positive predictive value (PPV) was 2.2% (1.8-2.6%), and negative predictive value was 100% (100-100%). PPVs decreased in younger age groups (18-29, 30-39, 40-49 years).</p><p><strong>Conclusions: </strong>FIT performs excellently for patients aged 40-49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.</p>\",\"PeriodicalId\":9243,\"journal\":{\"name\":\"British Journal of Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41416-025-03154-7\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41416-025-03154-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:早发性结直肠癌(EOCRC)的发病率正在迅速上升,其诊断通常发生在比晚发性结直肠癌更晚期的阶段。由于缺乏对年轻患者的筛查,诊断依赖于症状表现。粪便免疫化学试验(FIT)是初级保健中具有CRC临床特征的患者的诊断分类工具,尽管其在50岁以下个体中的表现尚未得到很好的确定。方法:在2021年1月1日至2023年10月7日期间,英格兰西南北部38,117名年龄在18-49岁的有症状患者在初级保健中接受了FIT。FIT结果≥10µg Hb/g粪便被认为是阳性。在同一地区,在2021年1月1日至2024年10月10日期间记录了528例EOCRC诊断。结果:528例EOCRC患者中,105例(20%)在诊断前一年接受了FIT。FIT的敏感性为92.4% (95% CI 85.5-96.7%),特异性为88.5%(88.2-88.8%),阳性预测值(PPV)为2.2%(1.8-2.6%),阴性预测值为100%(100-100%)。较年轻年龄组(18-29岁、30-39岁、40-49岁)PPVs下降。结论:适合40 ~ 49岁患者;然而,它可能不适合患者使用
The diagnostic accuracy of the faecal immunochemical test for the detection of early-onset colorectal cancer: an age-stratified analysis in South West England.
Background: The incidence of early-onset colorectal cancer (EOCRC) is rising rapidly, with diagnoses typically occurring at a more advanced stage than late-onset CRC. In the absence of screening for younger patients, diagnosis relies on symptomatic presentation. The faecal immunochemical test (FIT) is a diagnostic triage tool for patients presenting with clinical features of CRC in primary care, though its performance in individuals under 50 years is not well established.
Methods: A cohort of 38,117 symptomatic patients aged 18-49 years in upper South West England underwent FIT in primary care between 01/01/2021 and 10/07/2023. A FIT result of ≥10 µg Hb/g faeces was considered positive. In the same region, 528 EOCRC diagnoses were recorded between 01/01/2021 and 10/10/2024.
Results: Of the 528 EOCRC patients, 105 (20%) underwent FIT in the year before diagnosis. The sensitivity of FIT was 92.4% (95% CI 85.5-96.7%), specificity was 88.5% (88.2-88.8%), positive predictive value (PPV) was 2.2% (1.8-2.6%), and negative predictive value was 100% (100-100%). PPVs decreased in younger age groups (18-29, 30-39, 40-49 years).
Conclusions: FIT performs excellently for patients aged 40-49; however, it may not be used optimally in patients <40 years. A more targeted strategy is needed to guide investigation in younger patients.
期刊介绍:
The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research.It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.